-+ 0.00%
-+ 0.00%
-+ 0.00%

Neuphoria Therapeutics Reports $15 Million Increase in License Revenue for Fiscal Year Ended June 30, 2025; Net Loss Narrows to $838,000 from $15.6 Million Year Over Year

Reuters·09/29/2025 20:47:32

Please log in to view news